Atria Investments LLC Abb Vie Inc. Transaction History

Atria Investments LLC

$7.36 Billion
Q2 2024

A detailed history of Atria Investments LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Atria Investments LLC holds 167,555 shares of ABBV stock, worth $32.6 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

167,555

Previous 177,504 5.6%

Holding current value

$32.6 Million

Previous $32.3 Million 11.09%

% of portfolio

0.39%

Previous 0.47%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $1.54 Million - $1.8 Million	-9,949 Reduced 5.6%	167,555 $28.7 Million
Q1 2024 May 21, 2024	BUY	$159.82 - $182.1 $2.02 Million - $2.3 Million	12,609 Added 7.65%	177,504 $32.3 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $916,828 - $1.03 Million	6,663 Added 4.21%	164,895 $25.6 Million
Q3 2023 Nov 07, 2023	BUY	$133.59 - $154.65 $1.34 Million - $1.55 Million	9,994 Added 6.74%	158,232 $23.6 Million
Q2 2023 Aug 04, 2023	SELL	$132.51 - $164.9 $1.92 Million - $2.39 Million	-14,483 Reduced 8.9%	148,238 $20 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $1.7 Million - $1.95 Million	11,728 Added 7.77%	162,721 $25.9 Million
Q4 2022 Jan 31, 2023	BUY	$138.31 - $165.87 $1.14 Million - $1.37 Million	8,259 Added 5.79%	150,993 $24.4 Million
Q3 2022 Nov 01, 2022	SELL	$134.21 - $153.93 $1.05 Million - $1.2 Million	-7,811 Reduced 5.19%	142,734 $19.2 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $1.11 Million - $1.41 Million	-8,073 Reduced 5.09%	150,545 $23.1 Million
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $2.49 Million - $3.09 Million	18,858 Added 13.49%	158,618 $25.7 Million
Q4 2021 Feb 04, 2022	BUY	$107.43 - $135.93 $1.21 Million - $1.53 Million	11,233 Added 8.74%	139,760 $18.9 Million
Q3 2021 Nov 16, 2021	BUY	$106.4 - $120.78 $1.06 Million - $1.21 Million	9,982 Added 8.42%	128,527 $13.9 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $2.45 Million - $2.73 Million	23,262 Added 24.41%	118,545 $13.4 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $909,447 - $1 Million	8,890 Added 10.29%	95,283 $10.3 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $787,836 - $1.06 Million	9,788 Added 12.78%	86,393 $9.26 Million
Q3 2020 Nov 05, 2020	BUY	$85.91 - $100.83 $553,518 - $649,647	6,443 Added 9.18%	76,605 $6.71 Million
Q2 2020 Sep 22, 2020	BUY	$73.37 - $98.18 $352,396 - $471,558	4,803 Added 7.35%	70,162 $6.89 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $886,036 - $1.34 Million	13,737 Added 26.61%	65,359 $4.98 Million
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $1.52 Million - $1.9 Million	21,077 Added 69.0%	51,622 $4.57 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $171,998 - $206,791	2,731 Added 9.82%	30,545 $2.31 Million
Q2 2019 Aug 26, 2019	BUY	$65.7 - $83.98 $1.83 Million - $2.34 Million	27,814 New	27,814 $1.8 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $2.51 Million - $2.96 Million	-32,582 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $152,741 - $188,371	1,962 Added 6.41%	32,582 $3 Million
Q3 2018 Oct 09, 2018	SELL	$88.91 - $98.84 $2.11 Million - $2.34 Million	-23,688 Reduced 43.62%	30,620 $2.9 Million
Q2 2018 Jul 13, 2018	BUY	$89.78 - $106.23 $400,329 - $473,679	4,459 Added 8.95%	54,308 $5.03 Million
Q1 2018 Apr 30, 2018	BUY	$92.01 - $123.21 $81,888 - $109,656	890 Added 1.82%	49,849 $4.72 Million
Q4 2017 Jan 16, 2018	SELL	$89.56 - $98.21 $2.53 Million - $2.77 Million	-28,210 Reduced 36.56%	48,959 $4.74 Million
Q3 2017 Oct 12, 2017	BUY	$69.85 - $89.22 $5.39 Million - $6.89 Million	77,169	77,169 $6.86 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.

Account

Atria Investments LLC Abb Vie Inc. Transaction History